1. Home
  2. ELME vs FATE Comparison

ELME vs FATE Comparison

Compare ELME & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$1.66

Market Cap

147.5M

Sector

Real Estate

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.53

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
FATE
Founded
1960
2007
Country
United States
United States
Employees
91
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.5M
125.6M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ELME
FATE
Price
$1.66
$2.53
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$12.67
$4.10
AVG Volume (30 Days)
631.0K
1.2M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
707.44%
N/A
EPS Growth
N/A
29.88
EPS
N/A
N/A
Revenue
$206,360,000.00
$6,646,000.00
Revenue This Year
$5.03
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$0.94
52 Week High
$17.68
$3.23

Technical Indicators

Market Signals
Indicator
ELME
FATE
Relative Strength Index (RSI) 51.12 52.88
Support Level $1.46 $2.27
Resistance Level $1.67 $2.55
Average True Range (ATR) 0.03 0.13
MACD -0.00 0.01
Stochastic Oscillator 40.00 59.04

Price Performance

Historical Comparison
ELME
FATE

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. It derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Elme Communities' tenants are banking, consulting, law, and financial services firms. The company operates in a single reportable segment which includes the ownership, development, redevelopment and acquisition of apartment communities.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: